Ionis Pharmaceuticals’ $575 Million Convertible Senior Notes Offering

Pietro Martinoia
Tagged:

Cooley advised Ionis Pharmaceuticals on the offering.Ionis Pharmaceuticals, a biotechnology company, announced the offering of $575 million aggregate principal amount of convertible senior notes, including the exercise in…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Pietro Martinoia

…

This content is for Standard 1 Year members only.
Login Join Now